血液类风湿学和全身氧化状况在患有巨症的患者
Emine Kilic-Toprak1, Guzin Fidan Yaylali2, Yasin Ozdemir3
1Faculty of Medicine, Department of Physiology, Pamukkale University, Kinikli, Denizli, Turkey.
Biorheology
|February 20, 2025
概括
活跃和受控的壮病患者表现出红细胞 (RBC) 变形能力受损和红细胞聚合增加. 这项研究突出显示了壮症的血液变化,独立于氧化应激水平.
科学领域:
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
- 心血管医学 心血管医学
背景情况:
- 已知心血管并发症在壮症.
- 血学变化和壮症中的全身氧化状态仍未得到充分研究.
研究的目的:
- 在壮病患者中研究出血病学和全身氧化应激.
- 为了评估红细胞聚合和可变形性在活跃和受控的缩.
主要方法:
- 红细胞聚合指数 (AI),聚合半衰期 (t1⁄2),振幅 (Amp) 和红细胞延长指数 (EI) 均使用赤血细胞计进行测量.
- 血清总氧化状态 (TOS),总抗氧化状态 (TAS) 和氧化应激指数 (OSI) 都被量化.
- 这项研究包括19名活跃壮症 (AA),15名受控壮症 (CA) 患者和29名对照患者.
主要成果:
- 在对照组,AA组和CA组中观察到EI和AI的显著差异.
- 红细胞延长指数 (EI) 的降低表明可变形性降低.
- 减少聚合半时 (t1⁄2) 与增加AI相关,表明红细胞聚合增加.
- 血清TOS,TAS和OSI水平在各组之间没有显著差异.
结论:
- 壮症患者,无论疾病控制如何,都显示出红细胞变形能力降低.
- 红细胞聚合的增加是壮症中一个显著的血液学发现.
- 在这个患者队列中,系统性氧化应激标志物没有显著改变.
相关概念视频
Blood Flow
65.9K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
65.9K
Factors Affecting Erythropoiesis
3.0K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.0K


